A clinician should review your medical history, labs, and goals first to confirm it is appropriate for you
A newer peptide, Retatrutide , is a triple receptor agonist in development
Women exposed to GLP-1 RAs had a higher mean age of 34.2 years compared to those with other antidiabetic medications, with a mean age of 32.4 years
The Phase 3 TRIUMPH-4 trial recorded 39.4% of participants achieving 30% or more weight loss at the 12mg dose over 68 weeks
Genetic variation in CYP19A1 (the aromatase gene) produces meaningful differences in aromatase activity between individuals
It accelerates blood vessel formation (angiogenesis), modulates inflammatory pathways, and enhances collagen synthesis, all of which are crucial for tissue recovery